Heron Therapeutics, Inc. · NASDAQ:HRTX

Forbes William P exercised options for 12,500 Heron Therapeutics, Inc. shares (Form 4)

Traded Jun 6, 2026 · Filed Jun 8, 2026

On Jun 6, 2026, Forbes William P (EVP, Chief Development Officer) exercised options for 12,500 Heron Therapeutics, Inc. shares, leaving 221,611 shares. Filed Jun 8, 2026 (Form 4).

Options exercised
12,500 shares
Holding after
221,611 shares
Trading plan
No
Role
EVP, Chief Development Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 6, 2026Common StockOption exercise12,500221,611Direct

Source

View original at SEC

Related